Ivabradine: Do the Benefits Outweigh the Risks?

Abstract

Ivabradine is a selective I f current inhibitor that is used to lower the heart rate (HR) of patients with angina and/or heart failure. It is approved for use in several countries, including the United Kingdom, Australia, Saudi Arabia, and the United States. The drug was studied in several clinical trials, and it exhibited beneficial effects on the approved… (More)
DOI: 10.1177/1074248416672008

Topics

Cite this paper

@article{Alshammari2017IvabradineDT, title={Ivabradine: Do the Benefits Outweigh the Risks?}, author={Thamir M. Alshammari}, journal={Journal of cardiovascular pharmacology and therapeutics}, year={2017}, volume={22 3}, pages={210-218} }